Benedikt von Braunmühl

QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany.

Rentschler Biopharma SE develops and produces pharmaceutical products. Its solutions include bioprocess development, bio manufacturing, associated consulting activities including cell line process, cell culture, aseptic filling, consulting, planning and project management services. The company was founded in 1927 and is headquartered in Laupheim, Germany.

PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France.

IMD Institut für Medizinische Diagnostik GmbH is a medical laboratory company based in Berlin, Germany. and has subsidiaries in Germany. IMD Institut für Medizinische Diagnostik GmbH operates as medical laboratories. The CEO of the German company is Benedikt von Braunmühl.

Part of Institut für Medizinische Diagnostik MVZ GbR, NORDMED Healthcare GmbH is a German company that operates a general practitioner clinic. The company is based in Berlin, Germany. The company was founded in 1992. The CEO is Staffan Ternström.

Part of Medicover AB, Synevo GmbH is an investment holding German company. The company is based in Berlin, Germany. The CEOs are Benedikt von Braunmühl, Carl Fredrik Ragmark. The company was founded in 2007.

IMD MVZ Beteiligungs GmbH provides investment services. The private company is based in Berlin, Germany. The German company was founded in 2012. Benedikt von Braunmühl has been the CEO of the company since 2018.